AI
Tuesday, May 10, 2011 11:17:18 AM
In regards to Lymphoseek, they have a great setup with Cardinal Health which is a huge reason of Neoprobe's low cash burn rate of 1-1.5M per Quarter. Most if not all of the marketing/distribution cost is taken by Cardinal.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
